Swiss Re AG (LON:0QL6)

Sage Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40,677	33,735	25,602	22,429	21,131	19,244
Market Cap Growth	30.68%	31.77%	14.15%	6.14%	9.80%	-21.38%
Enterprise Value	43,689	36,070	30,655	28,343	25,250	22,664
PE Ratio	15.67	13.29	10.72	57.26	19.91	-
PS Ratio	1.20	0.95	0.79	0.59	0.61	0.61
PB Ratio	2.12	1.82	1.45	2.11	1.21	0.96
P/OCF Ratio	-	13.49	7.74	9.23	6.97	4.87
EV/Sales Ratio	1.21	1.02	0.95	0.74	0.73	0.71
EV/EBITDA Ratio	11.94	10.24	9.27	26.15	13.86	-
EV/EBIT Ratio	12.06	10.41	9.43	27.83	14.22	-
Debt / Equity Ratio	0.34	0.37	0.38	1.00	0.55	0.52
Debt / EBITDA Ratio	1.91	1.91	2.02	9.18	5.13	-
Quick Ratio	1.38	1.42	1.55	0.28	0.28	0.35
Current Ratio	2.49	2.55	2.93	0.37	0.38	0.47
Asset Turnover	0.33	0.34	0.27	0.26	0.26	0.21
Return on Equity (ROE)	14.25%	14.15%	17.77%	2.63%	5.64%	-2.83%
Return on Assets (ROA)	2.08%	2.08%	1.70%	0.43%	0.83%	-0.15%
Return on Capital (ROIC)	8.56%	8.62%	9.13%	2.46%	3.84%	-0.73%
Earnings Yield	6.38%	7.67%	9.54%	1.75%	5.02%	-3.34%
Earnings Yield	6.38%	7.67%	9.54%	1.75%	5.02%	-3.34%
Dividend Yield	3.80%	5.32%	6.71%	8.01%	8.26%	9.55%
Payout Ratio	-	61.03%	59.47%	386.65%	129.09%	-
Buyback Yield / Dilution	3.88%	0.49%	2.08%	0.15%	-4.98%	6.59%
Total Shareholder Return	7.68%	5.80%	8.79%	8.15%	3.28%	16.13%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.